1. Siegel RL, Miller KD, Jemal A.
Cancer statistics, 2019. CA Cancer J
Clin. 2019;69(1):7-34.
2. Ferlay J, Soerjomataram I, Dikshit
R, Eser S, Mathers C, Rebelo M, et
al. Cancer incidence and mortality
worldwide: sources, methods and
major patterns in GLOBOCAN 2012.
Int J Cancer. 2015;136(5):E359-86.
3. Huxley RR, Ansary-Moghaddam
A, Clifton P, Czernichow S, Parr
CL, Woodward M. The impact of
dietary and lifestyle risk factors
on risk of colorectal cancer: a
quantitative overview of the
epidemiological evidence. Int J
Cancer. 2009;125(1):171-80.
4. Villanueva A, Luedde T. The
transition from inflammation to
cancer in the liver. Clin Liver Dis
(Hoboken). 2016;8(4):89-93.
5. A B. The role of inflammation in liver
cancer. In: Aggarwal BB, Sung B,
Gupta SC, (Eds.). Inflammation and
Cancer: Advances in Experimental
Medicine and Biology; Springer:
Basel, Switzerland.401–35.
6. Luedde T, Schwabe RF. NF-κB in
the liver--linking injury, fibrosis
and hepatocellular carcinoma.
Nat Rev Gastroenterol Hepatol.
2011;8(2):108-18.
7. Zhang J, Wang WL, Li Q, Qiao Q.
Expression of transforming growth
factor-alpha and hepatitis B surface
antigen in human hepatocellular
carcinoma tissues and its
significance. World J Gastroenterol.
2004;10(6):830-3.
8. Soukupova J, Malfettone A,
Hyrossová P, Hernández-Alvarez
MI, Peñuelas-Haro I, Bertran E, et
al. Role of the Transforming Growth
Factor-β in regulating hepatocellular
carcinoma oxidative metabolism. Sci
Rep. 2017;7(1):12486.
9. Mena S, Ortega A, Estrela JM.
Oxidative stress in environmental-
induced carcinogenesis. Mutat Res.
2009;674(1-2):36-44.
10. Loft S, Møller P, Cooke MS, Rozalski
R, Olinski R. Antioxidant vitamins
and cancer risk: is oxidative damage
to DNA a relevant biomarker? Eur J
Nutr. 2008;47 Suppl 2:19-28.
11. Bruce WR, Giacca A, Medline A.
Possible mechanisms relating diet and
risk of colon cancer. Cancer Epidemiol
Biomarkers Prev. 2000;9(12):1271-9.
12. Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK,
et al. Medicinal plants and cancer
chemoprevention. Curr Drug Metab.
2008;9(7):581-91.
13. Verma S, Khambhala P, Joshi S,
Kothari V, Patel T, Seshadri S.
Evaluating the role of dithiolane
rich fraction of Ferula asafoetida
(apiaceae) for its antiproliferative and
apoptotic properties: in vitro studies.
Exp Oncol. 2019;41(2):90-4.
14. Sahebkar A, Iranshahi M. Biological
activities of essential oils from the
genus Ferula (Apiaceae). Asian
Biomedicine. 2010;4(6):835-47.
15. Duan H, Takaishi Y, Tori M, Takaoka
S, Honda G, Ito M, et al. Polysulfide
derivatives from Ferula foetida. J Nat
Prod. 2002;65(11):1667-9.
16. Chaudhary H, Jena PK, Seshadri S.
Evaluation of hydro-alcoholic extract
of Eclipta alba for its multidrug
resistance reversal potential:
an in vitro study. Nutr Cancer.
2013;65(5):775-80.
17. Mahendra P, Bisht S. Ferula
asafoetida: Traditional uses
and pharmacological activity.
Pharmacogn Rev. 2012;6(12):141-6.
18. Hanahan D, Weinberg RA.
The hallmarks of cancer. Cell.
2000;100(1):57-70.
19. Jagetia GC, Rao SK. Evaluation of
the antineoplastic activity of guduchi
(Tinospora cordifolia) in Ehrlich
ascites carcinoma bearing mice. Biol
Pharm Bull. 2006;29(3):460-6.
20. Kucharczak J, Simmons MJ,
Fan Y, Gélinas C. To be, or not
to be: NF-kappaB is the answer-
-role of Rel/NF-kappaB in the
regulation of apoptosis. Oncogene.
2003;22(56):8961-82.
21. Yamamoto Y, Gaynor RB.
Therapeutic potential of inhibition
of the NF-kappaB pathway in the
treatment of inflammation and cancer.
J Clin Invest. 2001;107(2):135-42.
22. Kim SM, Lee SY, Yuk DY, Moon
DC, Choi SS, Kim Y, et al. Inhibition
of NF-kappaB by ginsenoside Rg3
enhances the susceptibility of colon
cancer cells to docetaxel. Arch Pharm
Res. 2009;32(5):755-65.
23. Liu H, Li G, Zhang B, Sun D, Wu
J, Chen F, et al. Suppression of the
NF-κB signaling pathway in colon
cancer cells by the natural compound
Riccardin D from Dumortierahirsute.
Mol Med Rep. 2018;17(4):5837-43.
24. Babu TD, Kuttan G, Padikkala J.
Cytotoxic and anti-tumour properties
of certain taxa of Umbelliferae with
special reference to Centella asiatica
(L.) Urban. J Ethnopharmacol.
1995;48(1):53-7.
25. Mitra A CJ, Banerji A, Chatterjee
A, Das B The Multifaceted Role of
Curcumin in Cancer Prevention and
Treatment. J Environ Pathol Toxicol
Oncol 25(4):679–90.
26. Lind DS, Hochwald SN, Malaty J,
Rekkas S, Hebig P, Mishra G, et al.
Nuclear factor-kappa B is upregulated
in colorectal cancer. Surgery.
2001;130(2):363-9.
27. Hassanzadeh P. Colorectal cancer
and NF-κB signaling pathway.
Gastroenterol Hepatol Bed Bench.
2011;4(3):127-32.
28. Cha J-D, Kim Y-H, Kim J-Y. Essential
oil and 1,8-cineole from Artemisia
lavandulaefolia induces apoptosis in
KB cells via mitochondrial stress and
caspase activation. Food Science and
Biotechnology. 2010;19(1):185-91.
29. Jayaprakasha G, Murthy K, Uckoo
R, Patil B. Chemical composition of
volatile oil from Citrus limettioides
and their inhibition of colon cancer
cell proliferation. Industrial Crops and
Products. 2013;45:200-7.
30. Gomes MRF, Schuh RS, Jacques
ALB, Augustin OA, Bordignon
SAL, Dias DO, et al. Citotoxic
activity evaluation of essential
oils and nanoemulsions of Drimys
angustifolia and D. brasiliensis on
human glioblastoma (U-138 MG) and
human bladder carcinoma (T24) cell
lines in vitro. Revista Brasileira de
Farmacognosia. 2013;23.
31. Nanyonga K. Chemical composition,
antioxidant activity and cytotoxicity
of the essential oils of the leaves and
stem of Tarchonanthus camphoratus.
African Journal of Pharmacy and
Pharmacology. 2013;7:360-7.
32. Akrout A, Gonzalez LA, El Jani
H, Madrid PC. Antioxidant and
antitumor activities of Artemisia
campestris and Thymelaea hirsuta
from southern Tunisia. Food Chem
Toxicol. 2011;49(2):342-7.
33. Sorimachi K, Akimoto K, Koge
T. Inhibitory effect of Agaricu
blazei Murill components on
abnormal collagen fiber formation
in human hepatocarcinoma cells.
Biosci Biotechnol Biochem.
2008;72(2):621-3.
34. Zu Y, Yu H, Liang L, Fu Y, Efferth T,
Liu X, et al. Activities of ten essential
oils towards Propionibacterium acnes
and PC-3, A-549 and MCF-7 cancer
cells. Molecules. 2010;15(5):3200-10.
35. Asif M, Yehya AHS, Al-Mansoub
MA, Revadigar V, Ezzat MO,
Khadeer Ahamed MB, et al.
Anticancer attributes of Illicium
verum essential oils against colon
cancer. South African Journal of
Botany. 2016;103:156-61.
36. Itani W, El-Banna S, Hassan S, Larsson
R, Bazarbachi A, Gali-Muhtasib H.
Anti colon cancer components from
Lebanese sage (Salvia Libanotica)
essential oil. Cancer biology &
therapy. 2008;7:1765-73.
37. Çetinus E TT, Ergül M, Altun A,
Çetinus Ş, Kaya T. Thyme essential
oil inhibits proliferation of DLD-1
colorectal cancer cells through
antioxidant effect Cumhuriyet Med
J. 2013;35(1):14-24.
38. Da Silva S, Figueiredo P, Yano T.
Cytotoxic evaluation of essential oil
from Zanthoxylum rhoifolium Lam.
Leaves. Acta Amazonica. 2007;37.
39. Suffness MaP, J.M. Assays related
to cancer drug discovery. In:
Hostettmann(Ed.), Methods in Plant
Biochemistry: Assays for Bioactivity.
Methods in Plant Biochemistry 1990.
40. Zhou M, Liu X, Li Z, Huang Q, Li
F, Li CY. Caspase-3 regulates the
migration, invasion and metastasis
of colon cancer cells. Int J Cancer.
2018;143(4):921-30.
41. Olmos G, Lladó J. Tumor necrosis
factor alpha: a link between
neuroinflammation and excitotoxicity.
Mediators Inflamm. 2014;2014:861231.
42. Kuribayashi K, Finnberg N, Jeffers
JR, Zambetti GP, El-Deiry WS. The
relative contribution of pro-apoptotic
p53-target genes in the triggering of
apoptosis following DNA damage
in vitro and in vivo. Cell Cycle.
2011;10(14):2380-9.
43. Gradzka I. [Mechanisms and
regulation of the programmed
cell death]. Postepy Biochem.
2006;52(2):157-65.
)